• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成纤维细胞生长因子 21 在 1 型糖尿病及其并发症中的作用。

The role of FGF21 in type 1 diabetes and its complications.

机构信息

The Center of Cardiovascular Disorders, the First Hospital of Jilin University, Changchun, China.

Pediatrics Research Institute, Department of Pediatrics, University of Louisville, Louisville, Kentucky, USA.

出版信息

Int J Biol Sci. 2018 Jun 2;14(9):1000-1011. doi: 10.7150/ijbs.25026. eCollection 2018.

DOI:10.7150/ijbs.25026
PMID:29989062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6036735/
Abstract

Data from the International Diabetes Federation show that 347 million people worldwide have diabetes, and the incidence is still rising. Although the treatment of diabetes has been advanced, the current therapeutic options and outcomes, complications, are yet far from ideal. Therefore, an urgent need exists for the development of more effective therapies. Numerous studies have been conducted to establish and confirm whether FGF21 exerts beneficial effects on obesity and diabetes along with its complications. However, most of the studies associated with FGF21 were conducted in the patients with type 2 diabetes. Subsequently, the effect of FGF21 in the prevention or treatment of type 1 diabetes and its complications were also increasingly reported. In this review, we summarize the findings available on the function of FGF21 and the status of FGF21's treatment for type 1 diabetes. Based on the available information, we found that FGF21 exerts a hypoglycemic effect, restores the function of brown fat, and inhibits various complications in type 1 diabetes patients. Although these features are predominantly similar to those observed in the studies that showed the beneficial impact of FGF21 on type 2 diabetes and its complications, there are also certain distinct features and findings that may be of provide important and instructive for us to understand mechanistic insights and further promote the prevention and treatment of type 1 diabetes.

摘要

国际糖尿病联合会的数据显示,全球有 3.47 亿人患有糖尿病,且发病率仍在上升。尽管糖尿病的治疗已经取得了进展,但目前的治疗选择和结果,以及并发症,仍远不理想。因此,迫切需要开发更有效的治疗方法。许多研究已经证实,FGF21 对肥胖和糖尿病及其并发症具有有益作用。然而,大多数与 FGF21 相关的研究都是在 2 型糖尿病患者中进行的。随后,FGF21 在预防或治疗 1 型糖尿病及其并发症方面的作用也越来越多地被报道。在这篇综述中,我们总结了关于 FGF21 功能的研究结果以及 FGF21 治疗 1 型糖尿病的现状。根据现有资料,我们发现 FGF21 具有降血糖、恢复棕色脂肪功能和抑制 1 型糖尿病患者各种并发症的作用。尽管这些特征主要与那些表明 FGF21 对 2 型糖尿病及其并发症具有有益影响的研究相似,但也存在一些明显的特征和发现,这可能为我们理解机制提供重要的启示,并进一步促进 1 型糖尿病的预防和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36f0/6036735/f46d58bf69a0/ijbsv14p1000g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36f0/6036735/fbc6e2a6ff31/ijbsv14p1000g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36f0/6036735/2b59ffb720c8/ijbsv14p1000g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36f0/6036735/f46d58bf69a0/ijbsv14p1000g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36f0/6036735/fbc6e2a6ff31/ijbsv14p1000g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36f0/6036735/2b59ffb720c8/ijbsv14p1000g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36f0/6036735/f46d58bf69a0/ijbsv14p1000g004.jpg

相似文献

1
The role of FGF21 in type 1 diabetes and its complications.成纤维细胞生长因子 21 在 1 型糖尿病及其并发症中的作用。
Int J Biol Sci. 2018 Jun 2;14(9):1000-1011. doi: 10.7150/ijbs.25026. eCollection 2018.
2
Multiple roles of fibroblast growth factor 21 in metabolism.成纤维细胞生长因子21在代谢中的多重作用。
Curr Pharm Des. 2015;21(21):3041-50. doi: 10.2174/1381612821666150212155239.
3
Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.最近发现的代谢激素成纤维细胞生长因子 21 的生物学作用、临床意义和治疗可能性。
Eur J Endocrinol. 2012 Sep;167(3):301-9. doi: 10.1530/EJE-12-0357. Epub 2012 Jun 27.
4
Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus.成纤维细胞生长因子 21 作为 2 型糖尿病治疗靶点的新进展。
Med Res Rev. 2016 Jul;36(4):672-704. doi: 10.1002/med.21390. Epub 2016 Mar 31.
5
Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus.1型糖尿病患者血清成纤维细胞生长因子21与糖尿病并发症及胰岛素剂量的关联
PLoS One. 2022 Feb 22;17(2):e0263774. doi: 10.1371/journal.pone.0263774. eCollection 2022.
6
Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic properties in obesity/type 2 diabetes mellitus.成纤维细胞生长因子21:一种在肥胖/2型糖尿病中具有潜在治疗特性的新型代谢调节因子。
Physiol Res. 2009;58(1):1-7. doi: 10.33549/physiolres.931610.
7
Impact of FGF21 on glycemic control.成纤维细胞生长因子21对血糖控制的影响。
Horm Mol Biol Clin Investig. 2017 Jun 3;30(2):/j/hmbci.2017.30.issue-2/hmbci-2017-0001/hmbci-2017-0001.xml. doi: 10.1515/hmbci-2017-0001.
8
Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.非诺贝特通过成纤维细胞生长因子21/沉默信息调节因子1增加心脏自噬,并预防1型糖尿病小鼠心脏的纤维化和炎症。
Clin Sci (Lond). 2016 Apr;130(8):625-41. doi: 10.1042/CS20150623. Epub 2016 Jan 21.
9
FGF21: a novel prospect for the treatment of metabolic diseases.成纤维细胞生长因子21:治疗代谢性疾病的新前景。
Curr Opin Investig Drugs. 2009 Apr;10(4):359-64.
10
The role of fibroblast growth factor 21 in diabetes and its complications: A review from clinical perspective.成纤维细胞生长因子21在糖尿病及其并发症中的作用:临床视角综述
Diabetes Res Clin Pract. 2015 Jun;108(3):382-9. doi: 10.1016/j.diabres.2015.02.032. Epub 2015 Mar 3.

引用本文的文献

1
Adipose stromal cells increase insulin sensitivity and decrease liver gluconeogenesis in a mouse model of type 1 diabetes mellitus.在1型糖尿病小鼠模型中,脂肪基质细胞可提高胰岛素敏感性并减少肝脏糖异生。
Stem Cell Res Ther. 2025 Mar 11;16(1):133. doi: 10.1186/s13287-025-04225-5.
2
Skin advanced glycation end-products as indicators of the metabolic profile in diabetes mellitus: correlations with glycemic control, liver phenotypes and metabolic biomarkers.皮肤糖基化终产物作为糖尿病代谢特征的指标:与血糖控制、肝脏表型和代谢生物标志物的相关性。
BMC Endocr Disord. 2024 Mar 5;24(1):31. doi: 10.1186/s12902-024-01558-9.
3
Fibroblast Growth Factor 21: A More Effective Biomarker Than Free Fatty Acids and Other Insulin Sensitivity Measures for Predicting Non-alcoholic Fatty Liver Disease in Saudi Arabian Type 2 Diabetes Patients.

本文引用的文献

1
Fibroblast growth factor 21 decreases after liver fat reduction via growth hormone augmentation.通过增强生长激素降低肝脏脂肪后,成纤维细胞生长因子21减少。
Growth Horm IGF Res. 2017 Dec;37:1-6. doi: 10.1016/j.ghir.2017.10.002. Epub 2017 Oct 7.
2
FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes.成纤维细胞生长因子 21(FGF21)可改善肥胖糖尿病易感小鼠模型的葡萄糖稳态,而与体脂变化无关。
Diabetologia. 2017 Nov;60(11):2274-2284. doi: 10.1007/s00125-017-4389-x. Epub 2017 Aug 2.
3
FGF21 Attenuates High-Fat Diet-Induced Cognitive Impairment via Metabolic Regulation and Anti-inflammation of Obese Mice.
成纤维细胞生长因子21:在预测沙特阿拉伯2型糖尿病患者非酒精性脂肪性肝病方面,比游离脂肪酸及其他胰岛素敏感性指标更有效的生物标志物。
Cureus. 2023 Dec 14;15(12):e50524. doi: 10.7759/cureus.50524. eCollection 2023 Dec.
4
The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM).二甲双胍对 2 型糖尿病(T2DM)中成纤维细胞生长因子 21 的潜在影响。
Inflammopharmacology. 2023 Aug;31(4):1751-1760. doi: 10.1007/s10787-023-01255-4. Epub 2023 Jun 19.
5
Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis.基于生物信息学分析鉴定与 1 型糖尿病相关的候选生物标志物和通路。
Sci Rep. 2022 Jun 1;12(1):9157. doi: 10.1038/s41598-022-13291-1.
6
Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus.1型糖尿病患者血清成纤维细胞生长因子21与糖尿病并发症及胰岛素剂量的关联
PLoS One. 2022 Feb 22;17(2):e0263774. doi: 10.1371/journal.pone.0263774. eCollection 2022.
7
Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism.成纤维细胞生长因子 21 通过抗炎和抗氧化机制减轻盐敏感性高血压引起的肾病。
Mol Med. 2021 Nov 13;27(1):147. doi: 10.1186/s10020-021-00408-x.
8
Increasing hepatic glycogen moderates the diabetic phenotype in insulin-deficient Akita mice.增加肝糖原可改善胰岛素缺乏型阿基塔小鼠的糖尿病表型。
J Biol Chem. 2021 Jan-Jun;296:100498. doi: 10.1016/j.jbc.2021.100498. Epub 2021 Mar 2.
9
Serum Fibroblast Growth Factor 21 in Patients with and without Pterygia.患有和未患翼状胬肉患者的血清成纤维细胞生长因子21
J Ophthalmic Vis Res. 2020 Feb 2;15(1):38-44. doi: 10.18502/jovr.v15i1.5940. eCollection 2020 Jan-Mar.
成纤维细胞生长因子 21 通过肥胖小鼠的代谢调节和抗炎作用减轻高脂饮食诱导的认知障碍。
Mol Neurobiol. 2018 Jun;55(6):4702-4717. doi: 10.1007/s12035-017-0663-7. Epub 2017 Jul 15.
4
Fatty liver and FGF21 physiology.脂肪肝与成纤维细胞生长因子21生理学
Exp Cell Res. 2017 Nov 1;360(1):2-5. doi: 10.1016/j.yexcr.2017.05.006. Epub 2017 May 23.
5
The role of fibroblast growth factor 21 in atherosclerosis.成纤维细胞生长因子 21 在动脉粥样硬化中的作用。
Atherosclerosis. 2017 Feb;257:259-265. doi: 10.1016/j.atherosclerosis.2016.11.033. Epub 2016 Dec 1.
6
Therapeutics Targeting FGF Signaling Network in Human Diseases.靶向人类疾病中 FGF 信号网络的治疗策略。
Trends Pharmacol Sci. 2016 Dec;37(12):1081-1096. doi: 10.1016/j.tips.2016.10.003. Epub 2016 Oct 27.
7
Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice.成纤维细胞生长因子21缺失加重1型糖尿病小鼠主动脉中糖尿病诱导的病理变化。
Cardiovasc Diabetol. 2015 Jun 11;14(1):77. doi: 10.1186/s12933-015-0241-0.
8
G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.G蛋白偶联胆汁酸受体在小鼠胆汁酸代谢和禁食诱导的肝脂肪变性中起关键作用。
Hepatology. 2017 Mar;65(3):813-827. doi: 10.1002/hep.28707. Epub 2016 Jul 30.
9
Impaired Mitochondrial Fat Oxidation Induces FGF21 in Muscle.线粒体脂肪氧化受损会诱导肌肉中FGF21的产生。
Cell Rep. 2016 May 24;15(8):1686-99. doi: 10.1016/j.celrep.2016.04.057. Epub 2016 May 12.
10
Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus.成纤维细胞生长因子 21 作为 2 型糖尿病治疗靶点的新进展。
Med Res Rev. 2016 Jul;36(4):672-704. doi: 10.1002/med.21390. Epub 2016 Mar 31.